KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation ExpenseEBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingShares RepurchasedShort-Term Debt issuancesWages, Salaries and Other
Ratios

Chemed (CHE) Leases (2019 - 2026)

Chemed filings provide 8 years of Leases readings, the most recent being $133.6 million for Q1 2026.

  • For the quarter ending Q1 2026, Leases rose 1.87% year-over-year to $133.6 million, compared with a TTM value of $133.6 million through Mar 2026, up 1.87%, and an annual FY2025 reading of $131.2 million, up 3.01% over the prior year.
  • Leases hit $133.6 million in Q1 2026 for Chemed, up from $131.2 million in the prior quarter.
  • The five-year high for Leases was $135.7 million in Q4 2022, with the low at $123.4 million in Q3 2023.
  • Median Leases over the past 5 years was $131.2 million (2023), compared with a mean of $130.6 million.
  • The sharpest move saw Leases dropped 6.84% in 2023, then increased 8.72% in 2024.
  • Year by year, Leases stood at $135.7 million in 2022, then fell by 6.84% to $126.4 million in 2023, then increased by 0.74% to $127.3 million in 2024, then rose by 3.01% to $131.2 million in 2025, then increased by 1.87% to $133.6 million in 2026.
  • According to Business Quant data, Leases over the past three periods came in at $133.6 million, $131.2 million, and $128.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.